Skip to content
Gigantum.net
Business

Kimball Electronics (KE) Bets Big On Medical Devices And Debt Paydown

On August 12, Kimball Electronics (NASDAQ:KE) reported fourth-quarter results for the period ended June 30, along with guidance for fiscal 2027. Net sales fo...

· 424 words

On August 12, Kimball Electronics (NASDAQ: KE ) reported fourth-quarter results for the period ended June 30, along with guidance for fiscal 2027. Net sales for the quarter came in at $371.6 million, a 5% sequential increase, with every end-market vertical posting gains. The company framed the year ahead around growth generated internally plus the added contribution from its newly acquired Helvoet Polymer Technologies business. Behind that outlook sits a full fiscal year in which total sales actually fell 4%, which sets up a real tension between where Kimball Electronics has been and where it says it is going.

Cash generation was the clearest bright spot. Kimball Electronics posted $42.4 million in cash from operations during the quarter, marking ten straight quarters in which operating cash flow has stayed positive. That cash helped push total debt down to $116.6 million, the lowest level in more than four years, while the company still held $88.9 million in cash and $322.4 million of borrowing capacity. Cash Conversion Days fell to 82, the strongest reading in 17 quarters, pointing to tighter working capital management than at any point in recent memory. That balance sheet strength gave the company room to repurchase 83,000 shares for $2.1 million in the quarter and 447,000 shares for $11.9 million across the full year.

Fiscal 2027 guidance calls for net sales of $1.535 billion to $1.56 billion, a 7% to 9% increase over fiscal 2026, split between 3% to 5% organic growth and roughly $60 million in sales from the newly acquired Helvoet. Medical is expected to post percentage growth somewhere between a strong single-digit and a modest double-digit pace, and to supply upward of a third of the company's total sales in fiscal 2027, extending a shift already visible in fiscal 2026, when Medical sales rose over 10% once a prior year consigned inventory sale is stripped out.

Despite the improving cash position, the top line has been shrinking. Full-year net sales fell 4% to $1.431 billion, and automotive, still Kimball Electronics' largest vertical at 46% of quarterly sales, dropped 7% for the year and 3% in the fourth quarter alone. Industrial sales excluding the divested AT&M business fell 5% both in the quarter and for the full year. Profitability looked uneven once one-time items are stripped out. Adjusted operating income margin for the quarter was 4.9%, down from 5.2% a year earlier. Adjusted diluted earnings per share swung from a positive $0.34 in the fourth quarter of fiscal 2025 to a loss of $0.01 in the same quarter this year.

Gathered from external sources. Rights to this text belong to whoever originally published it.

Wednesday, October 14, 2026

© 2026 Gigantum.net. Content gathered automatically from external sources; rights to each text belong to whoever originally published it.